Back to Journals » OncoTargets and Therapy » Volume 13

Bilirubin Can Be Used as a Prognostic Factor for Lung Adenocarcinoma Patients with EGFR Mutations

Total article views   HTML views PDF downloads Totals
4,470 Dovepress* 4,102+ 564 4,666
PubMed Central* 368 114 482
Totals 4,470 678 5,148
*Since 29 October 2020

View citations on PubMed Central and Google Scholar